Drugwatcher

Name

Drugwatcher

Legal name

Drugwatcher

Website

https://drugwatcher.org

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Legal Information & Referral Services

akta.pro primary industry

Pharmacovigilance, Medication Safety & Controlled Substance Diversion Monitoring (HLAFALAN)

Keywords

• Pharmaceutical litigation information
• Defective drug alerts
• Medical device lawsuits
• Legal referral services
• Consumer health advocacy

Headquarters

HQ city

Seattle

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Marketing or Sales, Technology or R&D, Operations

Revenue model

1. Attorney referral/lead generation: Drugwatcher generates revenue by connecting consumers who have been harmed by drugs or medical devices with a network of attorneys. The site facilitates case reviews and legal consultations, operating on a referral basis where they connect visitors with appropriate legal service providers.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Drugwatcher is a consumer information and legal referral platform that publishes educational content about defective drugs (including Paraquat, NEC, Elmiron, Risperdal, Invokana, Opioids, and Roundup) and medical devices (including Paragard IUD, Hernia Mesh, 3M Earplugs, Transvaginal Mesh, and Surgical Stapler), while connecting affected individuals with a vetted network of attorneys pursuing product liability and class action litigation. The platform provides free content to consumers and facilitates free case reviews through its attorney referral program.

Product overview

Drugwatcher is a consumer information and legal referral platform focused on defective drugs and medical devices. The platform operates as a unified resource that consolidates information about dangerous pharmaceuticals (Paraquat, Risperdal, Elmiron, Invokana, Opioids, Roundup) and medical devices (Paragard IUD, Hernia Mesh, 3M Earplugs, Transvaginal Mesh, Surgical Stapler), connecting affected individuals with attorneys through case review services. The service includes an educational blog with health and pharmaceutical industry content, and contact forms for free case evaluations.

Differentiator

Problem solved

Functional benefit

Products and services

• Drug Lawsuit Information

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Network of like-minded attorneyscoreImplementation/ SI/ Consulting PartnerDrugwatcher works with a team of attorneys who share their philosophy and are currently pursuing legal action against specific manufacturers of defective drugs and medical devices. The attorneys assist consumers in determining if, when, and how they can file a lawsuit.

Scale indicators2 records

Recent moves4 records

Expansion highlights3 records

Broad incumbents

• Drugs.com: Drugs.com is a large consumer drug-information portal with prescribing, side-effect, and recall content; it does not run an attorney-referral business, but it competes for the same pharmaceutical safety search queries that drive Drugwatcher's organic traffic.
• Nolo: Nolo is an established consumer legal information publisher with editorial resources on personal injury, product liability, and consumer rights — overlapping with the legal-information half of Drugwatcher's content library, though without its tight mass-tort vertical focus.
• Avvo: Avvo is a large attorney directory and legal information platform that also funnels consumer legal inquiries to lawyers, operating a broader version of the consumer-to-attorney matching model that Drugwatcher applies specifically to drug and device injury claims.
• FindLaw: FindLaw is a Thomson Reuters-owned legal information and attorney-directory platform that publishes consumer-facing legal content (including product liability topics) and supports lawyer referrals, providing a broader-incumbent comparable to Drugwatcher's content-plus-referral motion.
• WebMD: WebMD is a broad consumer health-information destination that captures significant share of drug- and device-related informational queries, representing the larger incumbent competitor for organic health-safety search demand that Drugwatcher also targets.

Direct peers

• Drugwatchers.com: Drugwatchers.com is a consumer drug-safety information site that similarly publishes content about dangerous drugs and medical devices and connects affected consumers with attorneys — making it the closest direct competitor to Drugwatcher in both content vertical and referral business model.
• ClassAction.org: ClassAction.org is a consumer class-action news and information site that covers defective drugs and medical devices and supports an attorney-referral pipeline, competing with Drugwatcher for both organic search traffic and plaintiff-firm lead generation.
• Top Class Actions: Top Class Actions covers ongoing class action and mass tort litigation, including many of the same drug and device lawsuits that Drugwatcher tracks, and similarly drives case referrals to plaintiff law firms through its informational content.
• Drug Dangers: Drug Dangers is a content-and-referral platform focused on harmful pharmaceutical side effects and defective medical devices, with a comparable affiliate/lead-generation model targeting the same consumer-and-attorney funnel as Drugwatcher.
• Consumer Notice: Consumer Notice publishes consumer-facing safety information about drugs, medical devices, and consumer products, and connects injured consumers to attorneys — overlapping directly with Drugwatcher's content + legal-referral motion.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/drugwatcherorg
• Facebookfacebook.com/drugwatchers
• LinkedInlinkedin.com/company/drugwatcher

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Drugwatcher